Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Dubuque, IA USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Dubuque, IA USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Iowa City, IA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Des Moines, IA USA |
|
10/12/2006 |
|
|
|
Details |
|
Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Des Moines, IA USA |
|
08/11/2006 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Des Moines, IA USA |
|
06/26/2006 |
|
|
|
Details |
|
Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
|
Des Moines, IA USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
|
Sioux City, IA USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Cedar Rapids, IA USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Des Moines, IA USA |
|
06/26/2006 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Sioux City, IA USA |
|
06/26/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Missouri Valley, IA USA |
|
06/26/2006 |
|
|
|
Details |
|
Phase I Clinical Trial: 2DG (2-Deoxyglucose ) + Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases |
|
Iowa City, IA USA |
|
04/30/2006 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Cedar Rapids, IA USA |
|
11/27/2005 |
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Sioux City, IA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Missouri Valley, IA USA |
|
11/27/2005 |
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Ames, IA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Des Moines, IA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Iowa City, IA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection
|
|
Iowa City, IA USA |
|
11/13/2005 |
|
|
|
Details |
|
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
|
Cedar Rapids, IA USA |
|
11/06/2005 |
|
|
|
|
|
Details |
|
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
|
Sioux City, IA USA |
|
11/06/2005 |
|
|
|
Details |
|
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
|
|
Iowa City, IA USA |
|
11/06/2005 |
|
|
|
|
|
